カテゴリ： 世界, 医療/バイオ, Market Monitor Global

卵巣炎用治療のグローバル市場展望 2023年-2029年：薬物療法、ホルモン補充療法、手術、その他

■ 英語タイトル：Oophoritis Treatment Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC16171）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC16171
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：110
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[卵巣炎用治療のグローバル市場展望 2023年-2029年：薬物療法、ホルモン補充療法、手術、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の卵巣炎用治療市場規模と予測を収録しています。・世界の卵巣炎用治療市場：売上、2018年-2023年、2024年-2029年
・世界の卵巣炎用治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の卵巣炎用治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「薬物療法」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

卵巣炎用治療のグローバル主要企業は、Mylan N.V.、 Teva Pharmaceutical Industries Ltd.、 Sanofi、 Abbott、 F. Hoffmann-La Roche Ltd.、 Pfizer Inc.、 Glaxo Smith Kline Plc、 Bristol Myers Squibb Company、 Johnson & Johnson Private Limited、 Novartis AG、 Boehringer Ingelheim International GmbH、 Bayer AG、 Lupin、 Aurobindo Pharma、 Eli Lilly and Company、 Astra Zeneca、 Merck & Co. Inc.、 Allergan、 Sun Pharmaceutical Industries Ltd.、 Sumitomo Corporationなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、卵巣炎用治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の卵巣炎用治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の卵巣炎用治療市場：タイプ別市場シェア、2022年
・薬物療法、ホルモン補充療法、手術、その他

世界の卵巣炎用治療市場：用途別、2018年-2023年、2024年-2029年
世界の卵巣炎用治療市場：用途別市場シェア、2022年
・病院、専門クリニック、在宅医療、その他

世界の卵巣炎用治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の卵巣炎用治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における卵巣炎用治療のグローバル売上、2018年-2023年
・主要企業における卵巣炎用治療のグローバル売上シェア、2022年
・主要企業における卵巣炎用治療のグローバル販売量、2018年-2023年
・主要企業における卵巣炎用治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Mylan N.V.、 Teva Pharmaceutical Industries Ltd.、 Sanofi、 Abbott、 F. Hoffmann-La Roche Ltd.、 Pfizer Inc.、 Glaxo Smith Kline Plc、 Bristol Myers Squibb Company、 Johnson & Johnson Private Limited、 Novartis AG、 Boehringer Ingelheim International GmbH、 Bayer AG、 Lupin、 Aurobindo Pharma、 Eli Lilly and Company、 Astra Zeneca、 Merck & Co. Inc.、 Allergan、 Sun Pharmaceutical Industries Ltd.、 Sumitomo Corporation

*************************************************************

・調査・分析レポートの概要
卵巣炎用治療市場の定義
市場セグメント
世界の卵巣炎用治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の卵巣炎用治療市場規模
世界の卵巣炎用治療市場規模：2022年 VS 2029年
世界の卵巣炎用治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの卵巣炎用治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の卵巣炎用治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：薬物療法、ホルモン補充療法、手術、その他
卵巣炎用治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、専門クリニック、在宅医療、その他
卵巣炎用治療の用途別グローバル売上・予測

・地域別市場分析
地域別卵巣炎用治療市場規模 2022年と2029年
地域別卵巣炎用治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Mylan N.V.、 Teva Pharmaceutical Industries Ltd.、 Sanofi、 Abbott、 F. Hoffmann-La Roche Ltd.、 Pfizer Inc.、 Glaxo Smith Kline Plc、 Bristol Myers Squibb Company、 Johnson & Johnson Private Limited、 Novartis AG、 Boehringer Ingelheim International GmbH、 Bayer AG、 Lupin、 Aurobindo Pharma、 Eli Lilly and Company、 Astra Zeneca、 Merck & Co. Inc.、 Allergan、 Sun Pharmaceutical Industries Ltd.、 Sumitomo Corporation
...

This research report provides a comprehensive analysis of the Oophoritis Treatment market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Oophoritis Treatment market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Oophoritis Treatment, challenges faced by the industry, and potential opportunities for market players.
The global Oophoritis Treatment market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Oophoritis Treatment market presents opportunities for various stakeholders, including Hospitals, Specialty Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Oophoritis Treatment market. Additionally, the growing consumer demand present avenues for market expansion.
The global Oophoritis Treatment market was valued at US$ 471.6 million in 2022 and is projected to reach US$ 721.9 million by 2029, at a CAGR of 6.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Oophoritis Treatment market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Oophoritis Treatment market.
Market Overview: The report provides a comprehensive overview of the Oophoritis Treatment market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Medications, Hormone Replacement Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Oophoritis Treatment market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Oophoritis Treatment market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Oophoritis Treatment market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Oophoritis Treatment market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Oophoritis Treatment market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Oophoritis Treatment market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Oophoritis Treatment, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Oophoritis Treatment market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Oophoritis Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Medications
Hormone Replacement Therapy
Surgery
Others
Market segment by Application
Hospitals
Specialty Clinics
Homecare
Others
Global Oophoritis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
Abbott
F. Hoffmann-La Roche Ltd.
Pfizer Inc.
Glaxo Smith Kline Plc
Bristol Myers Squibb Company
Johnson & Johnson Private Limited
Novartis AG
Boehringer Ingelheim International GmbH
Bayer AG
Lupin
Aurobindo Pharma
Eli Lilly and Company
Astra Zeneca
Merck & Co. Inc.
Allergan
Sun Pharmaceutical Industries Ltd.
Sumitomo Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oophoritis Treatment, market overview.
Chapter 2: Global Oophoritis Treatment market size in revenue.
Chapter 3: Detailed analysis of Oophoritis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oophoritis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Oophoritis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oophoritis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oophoritis Treatment Overall Market Size
2.1 Global Oophoritis Treatment Market Size: 2022 VS 2029
2.2 Global Oophoritis Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oophoritis Treatment Players in Global Market
3.2 Top Global Oophoritis Treatment Companies Ranked by Revenue
3.3 Global Oophoritis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Oophoritis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oophoritis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oophoritis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Oophoritis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Oophoritis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Oophoritis Treatment Market Size Markets, 2022 & 2029
4.1.2 Medications
4.1.3 Hormone Replacement Therapy
4.1.4 Surgery
4.1.5 Others
4.2 By Type – Global Oophoritis Treatment Revenue & Forecasts
4.2.1 By Type – Global Oophoritis Treatment Revenue, 2018-2023
4.2.2 By Type – Global Oophoritis Treatment Revenue, 2024-2029
4.2.3 By Type – Global Oophoritis Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oophoritis Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Homecare
5.1.5 Others
5.2 By Application – Global Oophoritis Treatment Revenue & Forecasts
5.2.1 By Application – Global Oophoritis Treatment Revenue, 2018-2023
5.2.2 By Application – Global Oophoritis Treatment Revenue, 2024-2029
5.2.3 By Application – Global Oophoritis Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Oophoritis Treatment Market Size, 2022 & 2029
6.2 By Region – Global Oophoritis Treatment Revenue & Forecasts
6.2.1 By Region – Global Oophoritis Treatment Revenue, 2018-2023
6.2.2 By Region – Global Oophoritis Treatment Revenue, 2024-2029
6.2.3 By Region – Global Oophoritis Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Oophoritis Treatment Revenue, 2018-2029
6.3.2 US Oophoritis Treatment Market Size, 2018-2029
6.3.3 Canada Oophoritis Treatment Market Size, 2018-2029
6.3.4 Mexico Oophoritis Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Oophoritis Treatment Revenue, 2018-2029
6.4.2 Germany Oophoritis Treatment Market Size, 2018-2029
6.4.3 France Oophoritis Treatment Market Size, 2018-2029
6.4.4 U.K. Oophoritis Treatment Market Size, 2018-2029
6.4.5 Italy Oophoritis Treatment Market Size, 2018-2029
6.4.6 Russia Oophoritis Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Oophoritis Treatment Market Size, 2018-2029
6.4.8 Benelux Oophoritis Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Oophoritis Treatment Revenue, 2018-2029
6.5.2 China Oophoritis Treatment Market Size, 2018-2029
6.5.3 Japan Oophoritis Treatment Market Size, 2018-2029
6.5.4 South Korea Oophoritis Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Oophoritis Treatment Market Size, 2018-2029
6.5.6 India Oophoritis Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Oophoritis Treatment Revenue, 2018-2029
6.6.2 Brazil Oophoritis Treatment Market Size, 2018-2029
6.6.3 Argentina Oophoritis Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Oophoritis Treatment Revenue, 2018-2029
6.7.2 Turkey Oophoritis Treatment Market Size, 2018-2029
6.7.3 Israel Oophoritis Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Oophoritis Treatment Market Size, 2018-2029
6.7.5 UAE Oophoritis Treatment Market Size, 2018-2029
7 Oophoritis Treatment Companies Profiles
7.1 Mylan N.V.
7.1.1 Mylan N.V. Company Summary
7.1.2 Mylan N.V. Business Overview
7.1.3 Mylan N.V. Oophoritis Treatment Major Product Offerings
7.1.4 Mylan N.V. Oophoritis Treatment Revenue in Global Market (2018-2023)
7.1.5 Mylan N.V. Key News & Latest Developments
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd. Oophoritis Treatment Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Ltd. Oophoritis Treatment Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Oophoritis Treatment Major Product Offerings
7.3.4 Sanofi Oophoritis Treatment Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Oophoritis Treatment Major Product Offerings
7.4.4 Abbott Oophoritis Treatment Revenue in Global Market (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Oophoritis Treatment Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Oophoritis Treatment Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Summary
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Oophoritis Treatment Major Product Offerings
7.6.4 Pfizer Inc. Oophoritis Treatment Revenue in Global Market (2018-2023)
7.6.5 Pfizer Inc. Key News & Latest Developments
7.7 Glaxo Smith Kline Plc
7.7.1 Glaxo Smith Kline Plc Company Summary
7.7.2 Glaxo Smith Kline Plc Business Overview
7.7.3 Glaxo Smith Kline Plc Oophoritis Treatment Major Product Offerings
7.7.4 Glaxo Smith Kline Plc Oophoritis Treatment Revenue in Global Market (2018-2023)
7.7.5 Glaxo Smith Kline Plc Key News & Latest Developments
7.8 Bristol Myers Squibb Company
7.8.1 Bristol Myers Squibb Company Company Summary
7.8.2 Bristol Myers Squibb Company Business Overview
7.8.3 Bristol Myers Squibb Company Oophoritis Treatment Major Product Offerings
7.8.4 Bristol Myers Squibb Company Oophoritis Treatment Revenue in Global Market (2018-2023)
7.8.5 Bristol Myers Squibb Company Key News & Latest Developments
7.9 Johnson & Johnson Private Limited
7.9.1 Johnson & Johnson Private Limited Company Summary
7.9.2 Johnson & Johnson Private Limited Business Overview
7.9.3 Johnson & Johnson Private Limited Oophoritis Treatment Major Product Offerings
7.9.4 Johnson & Johnson Private Limited Oophoritis Treatment Revenue in Global Market (2018-2023)
7.9.5 Johnson & Johnson Private Limited Key News & Latest Developments
7.10 Novartis AG
7.10.1 Novartis AG Company Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Oophoritis Treatment Major Product Offerings
7.10.4 Novartis AG Oophoritis Treatment Revenue in Global Market (2018-2023)
7.10.5 Novartis AG Key News & Latest Developments
7.11 Boehringer Ingelheim International GmbH
7.11.1 Boehringer Ingelheim International GmbH Company Summary
7.11.2 Boehringer Ingelheim International GmbH Business Overview
7.11.3 Boehringer Ingelheim International GmbH Oophoritis Treatment Major Product Offerings
7.11.4 Boehringer Ingelheim International GmbH Oophoritis Treatment Revenue in Global Market (2018-2023)
7.11.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
7.12 Bayer AG
7.12.1 Bayer AG Company Summary
7.12.2 Bayer AG Business Overview
7.12.3 Bayer AG Oophoritis Treatment Major Product Offerings
7.12.4 Bayer AG Oophoritis Treatment Revenue in Global Market (2018-2023)
7.12.5 Bayer AG Key News & Latest Developments
7.13 Lupin
7.13.1 Lupin Company Summary
7.13.2 Lupin Business Overview
7.13.3 Lupin Oophoritis Treatment Major Product Offerings
7.13.4 Lupin Oophoritis Treatment Revenue in Global Market (2018-2023)
7.13.5 Lupin Key News & Latest Developments
7.14 Aurobindo Pharma
7.14.1 Aurobindo Pharma Company Summary
7.14.2 Aurobindo Pharma Business Overview
7.14.3 Aurobindo Pharma Oophoritis Treatment Major Product Offerings
7.14.4 Aurobindo Pharma Oophoritis Treatment Revenue in Global Market (2018-2023)
7.14.5 Aurobindo Pharma Key News & Latest Developments
7.15 Eli Lilly and Company
7.15.1 Eli Lilly and Company Company Summary
7.15.2 Eli Lilly and Company Business Overview
7.15.3 Eli Lilly and Company Oophoritis Treatment Major Product Offerings
7.15.4 Eli Lilly and Company Oophoritis Treatment Revenue in Global Market (2018-2023)
7.15.5 Eli Lilly and Company Key News & Latest Developments
7.16 Astra Zeneca
7.16.1 Astra Zeneca Company Summary
7.16.2 Astra Zeneca Business Overview
7.16.3 Astra Zeneca Oophoritis Treatment Major Product Offerings
7.16.4 Astra Zeneca Oophoritis Treatment Revenue in Global Market (2018-2023)
7.16.5 Astra Zeneca Key News & Latest Developments
7.17 Merck & Co. Inc.
7.17.1 Merck & Co. Inc. Company Summary
7.17.2 Merck & Co. Inc. Business Overview
7.17.3 Merck & Co. Inc. Oophoritis Treatment Major Product Offerings
7.17.4 Merck & Co. Inc. Oophoritis Treatment Revenue in Global Market (2018-2023)
7.17.5 Merck & Co. Inc. Key News & Latest Developments
7.18 Allergan
7.18.1 Allergan Company Summary
7.18.2 Allergan Business Overview
7.18.3 Allergan Oophoritis Treatment Major Product Offerings
7.18.4 Allergan Oophoritis Treatment Revenue in Global Market (2018-2023)
7.18.5 Allergan Key News & Latest Developments
7.19 Sun Pharmaceutical Industries Ltd.
7.19.1 Sun Pharmaceutical Industries Ltd. Company Summary
7.19.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.19.3 Sun Pharmaceutical Industries Ltd. Oophoritis Treatment Major Product Offerings
7.19.4 Sun Pharmaceutical Industries Ltd. Oophoritis Treatment Revenue in Global Market (2018-2023)
7.19.5 Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
7.20 Sumitomo Corporation
7.20.1 Sumitomo Corporation Company Summary
7.20.2 Sumitomo Corporation Business Overview
7.20.3 Sumitomo Corporation Oophoritis Treatment Major Product Offerings
7.20.4 Sumitomo Corporation Oophoritis Treatment Revenue in Global Market (2018-2023)
7.20.5 Sumitomo Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Oophoritis Treatment Market Opportunities & Trends in Global Market
Table 2. Oophoritis Treatment Market Drivers in Global Market
Table 3. Oophoritis Treatment Market Restraints in Global Market
Table 4. Key Players of Oophoritis Treatment in Global Market
Table 5. Top Oophoritis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oophoritis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oophoritis Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oophoritis Treatment Product Type
Table 9. List of Global Tier 1 Oophoritis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oophoritis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Oophoritis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Oophoritis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oophoritis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Oophoritis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Oophoritis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oophoritis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Oophoritis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Oophoritis Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oophoritis Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Oophoritis Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oophoritis Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Oophoritis Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oophoritis Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Oophoritis Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oophoritis Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Oophoritis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oophoritis Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Oophoritis Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oophoritis Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Mylan N.V. Company Summary
Table 31. Mylan N.V. Oophoritis Treatment Product Offerings
Table 32. Mylan N.V. Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Mylan N.V. Key News & Latest Developments
Table 34. Teva Pharmaceutical Industries Ltd. Company Summary
Table 35. Teva Pharmaceutical Industries Ltd. Oophoritis Treatment Product Offerings
Table 36. Teva Pharmaceutical Industries Ltd. Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Oophoritis Treatment Product Offerings
Table 40. Sanofi Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Abbott Company Summary
Table 43. Abbott Oophoritis Treatment Product Offerings
Table 44. Abbott Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Key News & Latest Developments
Table 46. F. Hoffmann-La Roche Ltd. Company Summary
Table 47. F. Hoffmann-La Roche Ltd. Oophoritis Treatment Product Offerings
Table 48. F. Hoffmann-La Roche Ltd. Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 50. Pfizer Inc. Company Summary
Table 51. Pfizer Inc. Oophoritis Treatment Product Offerings
Table 52. Pfizer Inc. Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Inc. Key News & Latest Developments
Table 54. Glaxo Smith Kline Plc Company Summary
Table 55. Glaxo Smith Kline Plc Oophoritis Treatment Product Offerings
Table 56. Glaxo Smith Kline Plc Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Glaxo Smith Kline Plc Key News & Latest Developments
Table 58. Bristol Myers Squibb Company Company Summary
Table 59. Bristol Myers Squibb Company Oophoritis Treatment Product Offerings
Table 60. Bristol Myers Squibb Company Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol Myers Squibb Company Key News & Latest Developments
Table 62. Johnson & Johnson Private Limited Company Summary
Table 63. Johnson & Johnson Private Limited Oophoritis Treatment Product Offerings
Table 64. Johnson & Johnson Private Limited Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Johnson & Johnson Private Limited Key News & Latest Developments
Table 66. Novartis AG Company Summary
Table 67. Novartis AG Oophoritis Treatment Product Offerings
Table 68. Novartis AG Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Novartis AG Key News & Latest Developments
Table 70. Boehringer Ingelheim International GmbH Company Summary
Table 71. Boehringer Ingelheim International GmbH Oophoritis Treatment Product Offerings
Table 72. Boehringer Ingelheim International GmbH Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Boehringer Ingelheim International GmbH Key News & Latest Developments
Table 74. Bayer AG Company Summary
Table 75. Bayer AG Oophoritis Treatment Product Offerings
Table 76. Bayer AG Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Bayer AG Key News & Latest Developments
Table 78. Lupin Company Summary
Table 79. Lupin Oophoritis Treatment Product Offerings
Table 80. Lupin Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Lupin Key News & Latest Developments
Table 82. Aurobindo Pharma Company Summary
Table 83. Aurobindo Pharma Oophoritis Treatment Product Offerings
Table 84. Aurobindo Pharma Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. Aurobindo Pharma Key News & Latest Developments
Table 86. Eli Lilly and Company Company Summary
Table 87. Eli Lilly and Company Oophoritis Treatment Product Offerings
Table 88. Eli Lilly and Company Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 89. Eli Lilly and Company Key News & Latest Developments
Table 90. Astra Zeneca Company Summary
Table 91. Astra Zeneca Oophoritis Treatment Product Offerings
Table 92. Astra Zeneca Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 93. Astra Zeneca Key News & Latest Developments
Table 94. Merck & Co. Inc. Company Summary
Table 95. Merck & Co. Inc. Oophoritis Treatment Product Offerings
Table 96. Merck & Co. Inc. Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 97. Merck & Co. Inc. Key News & Latest Developments
Table 98. Allergan Company Summary
Table 99. Allergan Oophoritis Treatment Product Offerings
Table 100. Allergan Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 101. Allergan Key News & Latest Developments
Table 102. Sun Pharmaceutical Industries Ltd. Company Summary
Table 103. Sun Pharmaceutical Industries Ltd. Oophoritis Treatment Product Offerings
Table 104. Sun Pharmaceutical Industries Ltd. Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 105. Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 106. Sumitomo Corporation Company Summary
Table 107. Sumitomo Corporation Oophoritis Treatment Product Offerings
Table 108. Sumitomo Corporation Oophoritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 109. Sumitomo Corporation Key News & Latest Developments
List of Figures
Figure 1. Oophoritis Treatment Segment by Type in 2022
Figure 2. Oophoritis Treatment Segment by Application in 2022
Figure 3. Global Oophoritis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oophoritis Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oophoritis Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oophoritis Treatment Revenue in 2022
Figure 8. By Type - Global Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Oophoritis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Oophoritis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 16. US Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 28. China Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Oophoritis Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Oophoritis Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Mylan N.V. Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Pharmaceutical Industries Ltd. Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. F. Hoffmann-La Roche Ltd. Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Inc. Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Glaxo Smith Kline Plc Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol Myers Squibb Company Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Johnson & Johnson Private Limited Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novartis AG Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Boehringer Ingelheim International GmbH Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bayer AG Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Lupin Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Aurobindo Pharma Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Eli Lilly and Company Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Astra Zeneca Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Merck & Co. Inc. Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Allergan Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Sun Pharmaceutical Industries Ltd. Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Sumitomo Corporation Oophoritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 閉経後骨粗鬆症治療のグローバル市場展望 2023年-2029年：ビスホスホネート、ビタミンD3、エストロゲンアゴニスト/アンタゴニスト、ホルモン補充療法、副甲状腺ホルモン療法、その他
  • 足関節痛治療ソリューションのグローバル市場展望 2023年-2029年：薬物療法、理学療法
  • 皮膚糸状菌症治療のグローバル市場展望 2023年-2029年：Rx、OTC
  • サラセミア治療のグローバル市場展望 2023年-2029年：DFO、DFP、DFX、その他
  • 呼吸器疾患治療のグローバル市場展望 2023年-2029年：吸入＆点鼻薬、経口薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC16171 )"卵巣炎用治療のグローバル市場展望 2023年-2029年：薬物療法、ホルモン補充療法、手術、その他" (英文：Oophoritis Treatment Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。